Scientists found a molecule that helps tumours in an especially deadly form of breast cancer have grow and spread. The molecule, known as alpha v beta 6, could be used both to identify at-risk patients and develop new treatments, say scientists.
A study found high levels of alpha v beta 6 in 40% of tumours in women with HER2 positive breast cancer, a form of the disease that does not respond to conventional hormone therapy. These patients were twice as likely to die within five years of diagnosis as those with low levels of the molecule.
In experiments on mice with the same type of breast cancer, scientists used an antibody drug to block activity of alpha v beta 6. Combining the antibody with the drug Herceptin, which targets the cancer-driving HER2 protein, completely eradicated the animals' tumours after six weeks of treatment.
More top news
With lines catapulting right and centre in the complex investigation over Trump's links with Russia, this is how the story unfolded.
An incredible £5m has been raised in support of the survivors and families of victims injured or killed in the Manchester bomb attack.
Fourteen heroin overdoses have been reported in the north east of England in just 24 hours, police have said - including one death.